Cargando…

Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection

PURPOSE: Autoantibodies to intracellular ‘rods and rings’ structures (anti-rods/rings or anti-RR) are strongly associated with hepatitis C (HCV) patients treated with interferon-α/ribavirin (IFN/RBV) and are linked with non-responsiveness to IFN/RBV or relapse, especially in Italian patients. This i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calise, S. John, Bizzaro, Nicola, Nguyen, Thuy, Bassetti, Danila, Porcelli, Brunetta, Almi, Paolo, Barberio, Giuseppina, Pesce, Giampaola, Satoh, Minoru, Chan, Edward K. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108729/ https://www.ncbi.nlm.nih.gov/pubmed/27844412 http://dx.doi.org/10.1007/s13317-016-0087-9

Ejemplares similares

Anti-Rods/Rings: A Human Model of Drug-Induced Autoantibody Generation
por: Calise, S. John, et al.
Publicado: (2015)

The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics
por: Tonutti, Elio, et al.
Publicado: (2016)

Accuracy of receptor-based methods for detection of thyrotropin-receptor autoantibodies: a new automated third-generation immunoassay shows higher analytical and clinical sensitivity for the differential diagnosis of hyperthyroidism
por: Tozzoli, Renato, et al.
Publicado: (2010)

Standardization and Quality Assessment Under the Perspective of Automated Computer-Assisted HEp-2 Immunofluorescence Assay Systems
por: Cinquanta, Luigi, et al.
Publicado: (2021)

High Levels of Soluble Ctla-4 Are Present in Anti-Mitochondrial Antibody Positive, but Not in Antibody Negative Patients with Primary Biliary Cirrhosis
por: Saverino, Daniele, et al.
Publicado: (2014)

Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory
por: Tozzoli, Renato, et al.
Publicado: (2012)

Telaprevir
Publicado: (2012)

A new M23-based ELISA assay for anti-aquaporin 4 autoantibodies: diagnostic accuracy and clinical correlation
por: Tampoia, Marilina, et al.
Publicado: (2019)

Anti-Rods and Rings Autoantibodies in a Patient With Hepatitis C Virus Infection
por: Choi, Kyung Ho, et al.
Publicado: (2015)

Anti-rods and rings autoantibodies can occur in the hepatitis c-naïve population
por: SHAIKH, Y., et al.
Publicado: (2013)

Telaprevir Experience From Turkey
por: Komur, Suheyla, et al.
Publicado: (2015)

Cutaneous Eruption due to Telaprevir
por: Falcão, Eduardo Mastrangelo Marinho, et al.
Publicado: (2015)

Acute severe autoimmune hepatitis with anti-rods and rings autoantibodies; literature first evidence
por: Assandri, Roberto, et al.
Publicado: (2021)

The Soluble Form of CTLA-4 from Serum of Patients with Autoimmune Diseases Regulates T-Cell Responses
por: Simone, Rita, et al.
Publicado: (2014)

Comment to “Telaprevir Experience From Turkey”
por: Akar, Tarik, et al.
Publicado: (2015)

Effects of boceprevir and telaprevir on the pharmacokinetics of dolutegravir
por: Johnson, Mark, et al.
Publicado: (2014)

Autoantibody Profiles in Autoimmune Rheumatic Diseases
por: Bizzaro, Nicola
Publicado: (2019)

The Presence of Autoantibodies to Cytoplasmic Rod and Ring Particles in the Serum of Patients with Chronic Hepatitis C Virus Infection
por: Afsharzadeh, Fatemeh, et al.
Publicado: (2016)

Chemiluminescent immunoassay technology: what does it change in autoantibody detection?
por: Cinquanta, Luigi, et al.
Publicado: (2017)

Prevalence and Significance of Autoantibody Seropositivity in Children with Wilson’s Disease
por: Jańczyk, Wojciech, et al.
Publicado: (2023)

311 A Case of Glomerulonephritis With Dual Seropositive Autoantibodies
Publicado: (2023)

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy
por: Pradat, Pierre, et al.
Publicado: (2015)

Primary biliary cholangitis with contemporary presence of anti-mithocondrial and anti-rods and rings autoantibodies: literature first case
por: Assandri, Roberto
Publicado: (2019)

Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C
por: Karino, Y, et al.
Publicado: (2014)

Telaprevir-Induced DRESS Syndrome Associated With Salmonella typhi
por: Akar, Tarık, et al.
Publicado: (2015)

Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir
por: Gomes, Lenyta Oliveira, et al.
Publicado: (2018)

Compositional complexity of rods and rings
por: Schiavon, Cara R., et al.
Publicado: (2018)

Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection
por: Stinton, Laura M, et al.
Publicado: (2013)

Induction of Cytoplasmic Rods and Rings Structures by Inhibition of the CTP and GTP Synthetic Pathway in Mammalian Cells
por: Carcamo, Wendy C., et al.
Publicado: (2011)

Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update
por: Hysa, Elvis, et al.
Publicado: (2023)

Modeling Viral Evolutionary Dynamics after Telaprevir-Based Treatment
por: Haseltine, Eric L., et al.
Publicado: (2014)

Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir
por: D’Ambrosio, Roberta, et al.
Publicado: (2012)

Cost-effectiveness of Telaprevir Combination Therapy for Chronic Hepatitis C
por: Brogan, Anita J., et al.
Publicado: (2014)

Anti-DFS70 antibodies detected by specific methods in patients with thrombosis or recurrent pregnancy loss: no evidence of an association
por: Bizzaro, Nicola, et al.
Publicado: (2020)

Longitudinal Study of a Human Drug-Induced Model of Autoantibody to Cytoplasmic Rods/Rings following HCV Therapy with Ribavirin and Interferon-α
por: Keppeke, Gerson Dierley, et al.
Publicado: (2012)

Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization
por: Capuozzo, Maurizio, et al.
Publicado: (2013)

Pharmacokinetic characteristics of telaprevir in healthy Korean male subjects and comparisons with Japanese
por: Choi, Yewon, et al.
Publicado: (2018)

Plasmonic Spectral Splitting in Ring/Rod Metasurface
por: Muhammad, Naseer, et al.
Publicado: (2017)

Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies
por: Choi, May Y., et al.
Publicado: (2023)

Chronic Hepatitis C Therapy in Liver Cirrhosis Complicated by Telaprevir-Induced DRESS
por: Mousa, Omar Y. S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8k597famrj67tpmelkil624dnt